Key result
Stress links to cardiometabolic disease, with greater metabolic and cardiovascular burdens observed in women.
Why the study?
Emerging data indicate that stress is a modifiable risk factor for obesity, insulin resistance, and heart disease, with higher relative risk in women, but sex differences in stress-related physiological responses remain underexplored.
Do stressful experiences increase the risk of metabolic and cardiovascular disease in women?
Do stressful experiences increase the risk of metabolic and cardiovascular disease in women?
Stress is a modifiable risk factor that disproportionately contributes to obesity, metabolic disturbances, and cardiovascular disease in women.
Stress assessment warrants consideration in women with cardiometabolic risk; leaves open whether interventions alter outcomes.
Cardiovascular disease (CVD) has traditionally been viewed as a male disease; however, the relative risk for obesity and hypertension morbidity and mortality, major risk factors for CVD, is higher for women in the United States. Emerging epidemiological data strongly support stressful experiences as a modifiable risk factor for obesity, insulin resistance, and heart disease in women at all ages. Therefore, primary prevention of these diseases may be associated with both identifying and increasing the knowledge regarding the sex differences in emotional functioning associated with physiological responses to stress. The purpose of this review is to highlight the growing body of clinical and experimental studies showing that stress, obesity-associated metabolic disturbances, and CVD comorbidities are more prevalent in females. Overall, this review reveals the need for investigations to decipher the early origins of these comorbidities. Targeting the sources of behavioral/emotional stress through the trajectory of life has the potential to reduce the alarming projected rates for chronic disease in women.
No takes yet. Share an insight, caveat, or question.
Murphy et al. (2017) conducted a review in Cardiovascular disease and metabolic disease. Stress was evaluated. Stress is a modifiable risk factor for obesity, insulin resistance, and heart disease, with stress-related metabolic disturbances and cardiovascular comorbidities being more prevalent in women.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: